Myocardial blood flow and myocardial flow reserve values in 13N–ammonia myocardial perfusion PET/CT using a time-efficient protocol in patients without coronary artery disease

Autor: Opstal TSJ, Knol RJJ, Cornel JH, Wondergem M, van der Zant FM

Publikováno v: European Journal of Hybrid Imaging, Vol 2, Iss 1, Pp 1-11 (2018)

Abstract Background Cardiac imaging by means of myocardial Positron Emission Tomography/Computed Tomography (PET/CT) is being used increasingly to assess coronary artery disease, to guide revascularization decisions with more accuracy, and it allows

Externí odkaz: https://doaj.org/article/bfe311513874465c9ff10413ca9de4f2

Myocardial blood flow and myocardial flow reserve values in

Autor: Opstal, Tsj, Knol, Rjj, Cornel, Jh, Wondergem, M, van der Zant, Fm

Publikováno v: European Journal of Hybrid Imaging

Background Cardiac imaging by means of myocardial Positron Emission Tomography/Computed Tomography (PET/CT) is being used increasingly to assess coronary artery disease, to guide revascularization decisions with more accuracy, and it allows robust qu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e3154ac4cbe8ed2a5fb9e59f8d2bb3e8
https://pubmed.ncbi.nlm.nih.gov/29951642

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Virilisation of initially obscure origin in a postmenopausal woman.

Autor: Renckens CNM, van der Zant FM, Hasper MF, de Waard JWD

Publikováno v: BJOG: An International Journal of Obstetrics & Gynaecology; Jan2006, Vol. 113 Issue 1, p125-126, 2p

Prostate-specific Membrane Antigen Positron Emission Tomography Before Reaching the Phoenix Criteria for Biochemical Recurrence of Prostate Cancer After Radiotherapy: Earlier Detection of Recurrences.

Autor: van Altena EJE; Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands. Electronic address: e.vanaltena@amsterdamumc.nl., Jansen BHE; Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands., Korbee ML; Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands; Department of Urology, Northwest Clinics, Alkmaar, The Netherlands., Knol RJJ; Department of Nuclear Medicine, Northwest Clinics, Alkmaar, The Netherlands., Luining WI; Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands., Nieuwenhuijzen JA; Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands., Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands., van der Pas SL; Department of Epidemiology and Data Science, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands., van der Voort van Zyp JRN; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands., van der Zant FM; Department of Nuclear Medicine, Northwest Clinics, Alkmaar, The Netherlands., van Leeuwen PJ; Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Wondergem M; Department of Nuclear Medicine, Northwest Clinics, Alkmaar, The Netherlands., Vis AN; Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands.

Publikováno v: European urology oncology [Eur Urol Oncol] 2024 Oct 15. Date of Electronic Publication: 2024 Oct 15.